Skip to content

A randomized controlled double-blind study for transcranial direct current stimulation in the treatment of post stroke fatigue

A randomized controlled double-blind study for transcranial direct current stimulation in the treatment of post stroke fatigue

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000031120
Enrollment
Unknown
Registered
2020-03-22
Start date
2021-01-01
Completion date
Unknown
Last updated
2020-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post stroke fatigue

Interventions

Experimental group:Active tDCS

Sponsors

The First Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients who had a stroke in the past two weeks; 2. Patients who are prone to fatigue or fatigue after activity, can not be relieved after rest, and whose fatigue severity scale score is greater than or equal to 36; 3. Patients with any of the following symptoms: (1) It's hard to recover from rest or sleep; (2) motivation is retained and productivity is reduced, (3) Patients developed the self-perception of need to overcome this lack of vitality; (4) Fatigue affects daily life / tasks; (5) Fatigue lasts for several hours after exercise; (6) Fatigue has become an important problem; 4. Patients with clear consciousness and stable vital signs; 5. Patients with informed consent and voluntary participation.

Exclusion criteria

Exclusion criteria: 1. Patients who will use Sedatives, anesthetics, psychoactive drugs, muscle relaxants or Na+ and Ca2 + channel blockers, such as carbamazepine during the evaluation period; 2. Patients who rely on inhalers; 3. Patients with a course of more than one year; 4. Patients with any contraindications such as pacemaker, denture, metal prosthesis, etc.; 5. Patients with a history of epilepsy or epilepsy and confirmed by electroencephalogram; 6. With serious diseases such as heart, liver and kidney failure.

Design outcomes

Primary

MeasureTime frame
Fatigue severity scale (FSS);

Secondary

MeasureTime frame
Multidimensional Fatigue Index-20(MIF-20);Functional Assessment Chronic Illness Therapy (Fatigue) (FACIT-F);

Contacts

Public ContactWeiming Sun

The First Affiliated Hospital of Nanchang University

sunweiming08@126.com+86 13291419434

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026